| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | NEUTRAL | NEUTRAL | BUY | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | N/A | N/A | N/A | 27.73▲ | N/A |
| MA10 | N/A | N/A | N/A | N/A | N/A |
| MA20 | N/A | N/A | N/A | N/A | N/A |
| MA50 | N/A | N/A | N/A | N/A | N/A |
| MA100 | N/A | N/A | N/A | N/A | N/A |
| MA200 | N/A | N/A | N/A | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | N/A | N/A | N/A | N/A | N/A |
| RSI | N/A | N/A | N/A | N/A | N/A |
| STOCH | N/A | N/A | N/A | N/A | N/A |
| WILL %R | N/A | N/A | N/A | N/A | N/A |
| CCI | N/A | N/A | N/A | N/A | N/A |
|
Saturday, January 11, 2020 11:54 PM
Before it's here, it's on the Bloomberg Terminal.
|
|
Thursday, January 09, 2020 10:49 AM
NEW YORK, Jan. 09, 2020 (GLOBE NEWSWIRE) -- ArTara Therapeutics, Inc. (Nasdaq: TARA) (“ArTara” or the “Company”), a clinical-stage company developing treatments for rare and specialty diseases with ...
|
|
Thursday, January 09, 2020 10:42 AM
Shares of ArTara to commence trading on Nasdaq under new ticker symbol “TARA” effective January 10, 2020 Company completes previously announced equity financing of $42.5 million concurrently with the ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 17/01/20 | 28.02 | 28.30 | 27.03 | 28.00 | 2,500 |
| 16/01/20 | 28.00 | 28.00 | 26.952 | 27.82 | 5,300 |
| 15/01/20 | 27.00 | 29.70 | 27.00 | 28.00 | 4,800 |
| 14/01/20 | 26.00 | 28.273 | 26.00 | 27.00 | 18,100 |
| 13/01/20 | 22.55 | 28.679 | 22.55 | 27.85 | 16,100 |
|
|
||||
|
|
||||
|
|